ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,039Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 102

$614K Total Retail Price of All Prescriptions

Rank: 22 out of 102

538 Patients Receiving at Least One Drug in Part D
91% Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in South Dakota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 538 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 538 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 697 659 130 1 2
WARFARIN SODIUM 588 549 70 2 7
FUROSEMIDE 517 501 92 3 4
LEVOTHYROXINE SODIUM 513 447 89 4 1
SIMVASTATIN 456 391 91 5 3
LOSARTAN POTASSIUM 451 429 92 6 10
AMLODIPINE BESYLATE 407 393 79 7 6
METOPROLOL SUCCINATE 374 321 70 8 8
ATENOLOL 284 284 50 9 16
POTASSIUM CHLORIDE 274 274 58 10 9
ENALAPRIL MALEATE 226 213 38 11 81
HYDROCHLOROTHIAZIDE 189 189 38 12 18
METOPROLOL TARTRATE 175 175 36 13 12
HYDROCODONE-ACETAMINOPHEN 169 134 44 S3 14 13
CITALOPRAM HBR 165 160* 26 15 17
CLOPIDOGREL 160 155* 28 16 20
ALLOPURINOL 158 153* 22 17 25
CARVEDILOL 153 138 32 18 22
ISOSORBIDE MONONITRATE ER 136 136 21 19 39
LISINOPRIL 127 122* 24 20 5
TRAMADOL HCL 116 111* 33 21 15
ATORVASTATIN CALCIUM 116 116 25 21 11
FLUTICASONE PROPIONATE 113 108* 38 23 35
GABAPENTIN 112 91 25 24 19
CRESTOR 112 107* 22 24 26
METFORMIN HCL 106 88 22 26 14
ALENDRONATE SODIUM 101 88 21 27 24
KLOR-CON 10 96 91* 22 28 59
PREDNISONE 95 95 19 29 28
KLOR-CON M20 93 93 18 30 53
DIOVAN 91 <11 <11 31 41
AZITHROMYCIN 89 84* 66 32 56
TAMSULOSIN HCL 88 83* 15 33 21
LANTUS 87 87 13 34 44
DONEPEZIL HCL 86 86 15 35 27
FENTANYL 79 74* 16 S2 36 36
TRIAMTERENE-HCTZ 76 51 12 37 40
SERTRALINE HCL 74 69* 13 38 23
ROPINIROLE HCL 69 <11 <11 39 67
JANUVIA 69 58 13 39 60
MIRTAZAPINE 68 <11 <11 41 37
HYDRALAZINE HCL 65 <11 <11 42 97
AMITRIPTYLINE HCL 63 49 11 R 43 62
GLIPIZIDE ER 60 46 14 44 146
ALBUTEROL SULFATE 60 <11 <11 44 96
LEVOFLOXACIN 60 55* 42 44 63
DIGOXIN 59 54* 13 47 42
CYMBALTA 59 <11 <11 47 54
LABETALOL HCL 58 <11 <11 49 112
PAROXETINE HCL 58 53* 12 49 88
DIGOX 57 57 12 51 57
GLIPIZIDE XL 57 <11 <11 51 120
CARBIDOPA-LEVODOPA 56 <11 <11 53 72
IRBESARTAN 55 <11 <11 54 94
ALPRAZOLAM 55 55 16 B 54 45
GLIPIZIDE 54 54 11 56 66
POLYETHYLENE GLYCOL 3350 54 49* 17 56 33
PRAZOSIN HCL 53 <11 <11 58 229
BACLOFEN 52 <11 <11 59 147
ZOLPIDEM TARTRATE 50 31 14 60 31
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.